Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1997 Oct;41(10):2292–2294. doi: 10.1128/aac.41.10.2292

Pharmacokinetic study of cefodizime and ceftriaxone in sera and bones of patients undergoing hip arthroplasty.

F Scaglione 1, G De Martini 1, L Peretto 1, R Ghezzi 1, M Baratelli 1, M M Arcidiacono 1, F Fraschini 1
PMCID: PMC164111  PMID: 9333066

Abstract

The study was carried out to determine the concentrations of cefodizime (single 2-g intravenous [i.v.] dose) and ceftriaxone (single 2-g i.v. dose) in the sera and bones of 42 patients (18 women and 24 men) undergoing hip arthroplasty. The concentrations of cefodizime and ceftriaxone in cancellous and cortical bone appear to be related to the free levels in serum but not to the total levels in serum, so the concentrations of cephalosporins in bone must be compared with the free concentrations in serum. Both drugs diffuse well into bone, with concentrations exceeding the MIC at which 90% of the major pathogenic infecting organisms are inhibited.

Full Text

The Full Text of this article is available as a PDF (135.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barradell L. B., Brogden R. N. Cefodizime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs. 1992 Nov;44(5):800–834. doi: 10.2165/00003495-199244050-00008. [DOI] [PubMed] [Google Scholar]
  2. Bergamini T. M., Polk H. C., Jr Pharmacodynamics of antibiotic penetration of tissue and surgical prophylaxis. Surg Gynecol Obstet. 1989 Mar;168(3):283–289. [PubMed] [Google Scholar]
  3. Chan C. Y., Chan K., French G. L. Rapid high performance liquid chromatographic assay of cephalosporins in biological fluids. J Antimicrob Chemother. 1986 Oct;18(4):537–545. doi: 10.1093/jac/18.4.537. [DOI] [PubMed] [Google Scholar]
  4. Classen D. C., Evans R. S., Pestotnik S. L., Horn S. D., Menlove R. L., Burke J. P. The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection. N Engl J Med. 1992 Jan 30;326(5):281–286. doi: 10.1056/NEJM199201303260501. [DOI] [PubMed] [Google Scholar]
  5. Conte J. E., Jr Pharmacokinetics of cefodizime in volunteers with normal or impaired renal function. J Clin Pharmacol. 1994 Nov;34(11):1066–1070. doi: 10.1002/j.1552-4604.1994.tb01982.x. [DOI] [PubMed] [Google Scholar]
  6. Craig W. A. Interrelationship between pharmacokinetics and pharmacodynamics in determining dosage regimens for broad-spectrum cephalosporins. Diagn Microbiol Infect Dis. 1995 May-Jun;22(1-2):89–96. doi: 10.1016/0732-8893(95)00053-d. [DOI] [PubMed] [Google Scholar]
  7. Dellinger E. P., Gross P. A., Barrett T. L., Krause P. J., Martone W. J., McGowan J. E., Jr, Sweet R. L., Wenzel R. P. Quality standard for antimicrobial prophylaxis in surgical procedures. Infectious Diseases Society of America. Clin Infect Dis. 1994 Mar;18(3):422–427. doi: 10.1093/clinids/18.3.422. [DOI] [PubMed] [Google Scholar]
  8. DiPiro J. T., Cheung R. P., Bowden T. A., Jr, Mansberger J. A. Single dose systemic antibiotic prophylaxis of surgical wound infections. Am J Surg. 1986 Nov;152(5):552–559. doi: 10.1016/0002-9610(86)90228-x. [DOI] [PubMed] [Google Scholar]
  9. Drusano G. L. Role of pharmacokinetics in the outcome of infections. Antimicrob Agents Chemother. 1988 Mar;32(3):289–297. doi: 10.1128/aac.32.3.289. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Fleishaker J. C., McNamara P. J. Performance of a diffusional clearance model for beta-lactam antimicrobial agents as influenced by extravascular protein binding and interstitial fluid kinetics. Antimicrob Agents Chemother. 1985 Sep;28(3):369–374. doi: 10.1128/aac.28.3.369. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. LeBel M., Grégoire S., Caron M., Bergeron M. G. Difference in blister fluid penetration after single and multiple doses of ceftriaxone. Antimicrob Agents Chemother. 1985 Jul;28(1):123–127. doi: 10.1128/aac.28.1.123. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Leigh D. A., Marriner J., Nisbet D., Powell H. D., Church J. C., Wise K. Bone concentrations of cefuroxime and cefamandole in the femoral head in 96 patients undergoing total hip replacement surgery. J Antimicrob Chemother. 1982 Apr;9(4):303–311. doi: 10.1093/jac/9.4.303. [DOI] [PubMed] [Google Scholar]
  13. Lieberman J. R., Callaway G. H., Salvati E. A., Pellicci P. M., Brause B. D. Treatment of the infected total hip arthroplasty with a two-stage reimplantation protocol. Clin Orthop Relat Res. 1994 Apr;(301):205–212. [PubMed] [Google Scholar]
  14. Paniara O., Platsouka E., Dimopoulou H., Constantoulaki S. In vitro evaluation of cefodizime, cefuroxime, ceftriaxone against respiratory pathogens. J Chemother. 1994 Feb;6(1):35–38. doi: 10.1080/1120009x.1994.11741126. [DOI] [PubMed] [Google Scholar]
  15. Ryan D. M. Pharmacokinetics of antibiotics in natural and experimental superficial compartments in animals and humans. J Antimicrob Chemother. 1993 May;31 (Suppl 500):1–16. doi: 10.1093/jac/31.suppl_d.1. [DOI] [PubMed] [Google Scholar]
  16. Schäfer-Korting M., Korting H. C., Maass L., Klesel N., Grigoleit H. G., Mutschler E. Cefodizime penetration into skin suction blister fluid following a single intravenous dose. Eur J Clin Pharmacol. 1986;30(3):295–298. doi: 10.1007/BF00541531. [DOI] [PubMed] [Google Scholar]
  17. Shyu W. C., Quintiliani R., Nightingale C. H., Dudley M. N. Effect of protein binding on drug penetration into blister fluid. Antimicrob Agents Chemother. 1988 Jan;32(1):128–130. doi: 10.1128/aac.32.1.128. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Wenzel R. P. Preoperative prophylactic antibiotics: brief historical note. Infect Control Hosp Epidemiol. 1993 Mar;14(3):121–121. doi: 10.1086/646695. [DOI] [PubMed] [Google Scholar]
  19. Yuk J. H., Nightingale C. H., Quintiliani R. Clinical pharmacokinetics of ceftriaxone. Clin Pharmacokinet. 1989 Oct;17(4):223–235. doi: 10.2165/00003088-198917040-00002. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES